These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 25442322

  • 1. Novel benzenesulfonylureas containing thiophenylpyrazoline moiety as potential antidiabetic and anticancer agents.
    Kharbanda C, Alam MS, Hamid H, Javed K, Shafi S, Ali Y, Alam P, Pasha MA, Dhulap A, Bano S, Nazreen S, Haider S.
    Bioorg Med Chem Lett; 2014 Nov 15; 24(22):5298-303. PubMed ID: 25442322
    [Abstract] [Full Text] [Related]

  • 2. Antidiabetic effect of novel benzenesulfonylureas as PPAR-γ agonists and their anticancer effect.
    Kharbanda C, Alam MS, Hamid H, Javed K, Dhulap A, Bano S, Ali Y.
    Bioorg Med Chem Lett; 2015 Oct 15; 25(20):4601-5. PubMed ID: 26384286
    [Abstract] [Full Text] [Related]

  • 3. Synthesis, docking, in vitro and in vivo antidiabetic activity of pyrazole-based 2,4-thiazolidinedione derivatives as PPAR-γ modulators.
    Naim MJ, Alam O, Alam MJ, Shaquiquzzaman M, Alam MM, Naidu VGM.
    Arch Pharm (Weinheim); 2018 Apr 15; 351(3-4):e1700223. PubMed ID: 29400412
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Thiazolidine-2,4-diones derivatives as PPAR-γ agonists: synthesis, molecular docking, in vitro and in vivo antidiabetic activity with hepatotoxicity risk evaluation and effect on PPAR-γ gene expression.
    Nazreen S, Alam MS, Hamid H, Yar MS, Dhulap A, Alam P, Pasha MA, Bano S, Alam MM, Haider S, Kharbanda C, Ali Y, Pillai KK.
    Bioorg Med Chem Lett; 2014 Jul 15; 24(14):3034-42. PubMed ID: 24890090
    [Abstract] [Full Text] [Related]

  • 7. Discovery of thiazolidine-2,4-dione/biphenylcarbonitrile hybrid as dual PPAR α/γ modulator with antidiabetic effect: in vitro, in silico and in vivo approaches.
    Hidalgo-Figueroa S, Ramírez-Espinosa JJ, Estrada-Soto S, Almanza-Pérez JC, Román-Ramos R, Alarcón-Aguilar FJ, Hernández-Rosado JV, Moreno-Díaz H, Díaz-Coutiño D, Navarrete-Vázquez G.
    Chem Biol Drug Des; 2013 Apr 15; 81(4):474-83. PubMed ID: 23289972
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Design, synthesis, in silico molecular docking and biological evaluation of novel oxadiazole based thiazolidine-2,4-diones bis-heterocycles as PPAR-γ agonists.
    Nazreen S, Alam MS, Hamid H, Yar MS, Shafi S, Dhulap A, Alam P, Pasha MA, Bano S, Alam MM, Haider S, Ali Y, Kharbanda C, Pillai KK.
    Eur J Med Chem; 2014 Nov 24; 87():175-85. PubMed ID: 25255433
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Design, synthesis and molecular docking of thiazolidinedione based benzene sulphonamide derivatives containing pyrazole core as potential anti-diabetic agents.
    Naim MJ, Alam O, Alam MJ, Hassan MQ, Siddiqui N, Naidu VGM, Alam MI.
    Bioorg Chem; 2018 Feb 24; 76():98-112. PubMed ID: 29169079
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Design, synthesis, molecular modeling and anti-hyperglycemic evaluation of phthalimide-sulfonylurea hybrids as PPARγ and SUR agonists.
    El-Zahabi MA, Elbendary ER, Bamanie FH, Radwan MF, Ghareib SA, Eissa IH.
    Bioorg Chem; 2019 Oct 24; 91():103115. PubMed ID: 31310882
    [Abstract] [Full Text] [Related]

  • 14. Molecular Docking, Synthesis and Biological Evaluation of Sulphonylureas/ Guanidine Derivatives as Promising Antidiabetic Agent.
    Panchal II, Sen DJ, Patel AD, Shah U, Patel M, Navale A, Bhavsar V.
    Curr Drug Discov Technol; 2018 Oct 24; 15(4):315-325. PubMed ID: 28969569
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. In vivo anti-diabetic, antioxidant and molecular docking studies of 1, 2, 8-trihydroxy-6-methoxy xanthone and 1, 2-dihydroxy-6-methoxyxanthone-8-O-β-D-xylopyranosyl isolated from Swertia corymbosa.
    Mahendran G, Manoj M, Murugesh E, Sathish Kumar R, Shanmughavel P, Rajendra Prasad KJ, Narmatha Bai V.
    Phytomedicine; 2014 Sep 25; 21(11):1237-48. PubMed ID: 25172785
    [Abstract] [Full Text] [Related]

  • 17. Design, synthesis, molecular modeling and anti-hyperglycemic evaluation of quinazolin-4(3H)-one derivatives as potential PPARγ and SUR agonists.
    Ibrahim MK, Eissa IH, Alesawy MS, Metwaly AM, Radwan MM, ElSohly MA.
    Bioorg Med Chem; 2017 Sep 01; 25(17):4723-4744. PubMed ID: 28720328
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. In-vitro and in-vivo antiadipogenic, hypolipidemic and antidiabetic activity of Diospyros melanoxylon (Roxb).
    Rathore K, Singh VK, Jain P, Rao SP, Ahmed Z, Singh VD.
    J Ethnopharmacol; 2014 Sep 11; 155(2):1171-6. PubMed ID: 25010927
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.